Treatment-resistant Schizophrenia Clinical Trials
33 clinical trials for Treatment-resistant Schizophrenia across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia — RECRUITING · PHASE3
- A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s). — RECRUITING · PHASE3
- Magnetic Seizure Therapy for Schizophrenia - Trial — RECRUITING · NA
- Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial — RECRUITING · NA
- Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia — RECRUITING · NA
- Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations — RECRUITING · NA
- Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. — RECRUITING
- The significance of deviation in time from the 12-hour standard serum-clozapine monitoring — COMPLETED · PHASE4
- Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia ( Anew ) — COMPLETED · PHASE2
- Deep Brain Stimulation in Treatment Resistant Schizophrenia — TERMINATED · NA
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. — ACTIVE_NOT_RECRUITING · PHASE4
- Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia — SUSPENDED · NA
- An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine — TERMINATED · PHASE4
- Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia — NOT_YET_RECRUITING · NA
- Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia — ACTIVE_NOT_RECRUITING · NA
- Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia — COMPLETED · PHASE4
- Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) — COMPLETED · PHASE2
- Neural Biomarkers of Clozapine Response — COMPLETED
- Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation — OTHER · NA
- Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial. — OTHER · NA
- The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia — OTHER · PHASE1
- Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations — OTHER · NA
- The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset — OTHER
- Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis — OTHER · PHASE4
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care — COMPLETED
- Hippocampus DBS in Treatment-resistant Schizophrenia — OTHER · NA
- Telmisartan Pilot Study on Treatment Resistant Schizophrenia — TERMINATED · PHASE2
- Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia — COMPLETED · PHASE4
- SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia — OTHER · PHASE3
- Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia — COMPLETED · NA
- Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia — TERMINATED · PHASE3
- Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia — COMPLETED · NA
- Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients — COMPLETED · PHASE4
Refine this search